Apical-height radiation dosing produces outcomes comparable to conventional 5-mm dosing, with less toxicity in patients with small choroidal melanoma.
A recent study has shed new light on cure rates in uveal melanoma, presenting a clearer — although not necessarily brighter — view of the lifesaving potential of ocular treatment.
A 35-year-old presents with an asymptomatic elevated pigmented lesion in the left eye, with nodularity along the pupillary margin but with no feeder vessels or neovascularization.
An animal model of brachytherapy-induced retinopathy would help investigators understand the underlying pathophysiological mechanisms. Cleveland Clinic researchers are creating one, which could eventually help test promising therapeutics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New Cleveland Clinic research shows that serial hepatic USG — paired with confirmatory CT/MRI scans when needed — has high sensitivity and specificity for detecting asymptomatic uveal melanoma metastases.
Discover how Cleveland Clinic physicians are hoping to improve survival in uveal melanoma by identifying patients with micrometastases—and suppressing them before they progress to macrometastases.